Adverse events associated with mefloquine

BMJ

Volumn 313, Issue 7071, 1996, Pages 1552-

  Corbett, E L ^a   Doherty, J F ^a   Behrens, R H ^a  

^a HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; MEFLOQUINE; PROGUANIL;

ADULT; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; HUMAN; MENTAL DISEASE; NOTE; TRAVEL;

ADULT; ANTIMALARIALS; CHLOROGUANIDE; CHLOROQUINE; DRUG COMBINATIONS; HUMANS; MEFLOQUINE; MENTAL DISORDERS; TRAVEL;

EID: 85007726102     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.313.7071.1552b     Document Type: Letter

References (2)

1. Barrett PJ, Emmins PD, Clarke PD, Bradley DJ. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. BMJ 1996; 313: 525–8. (31 August.)
2. Cook GC. Malaria prophylaxis. BMJ 1995; 311: 190–191.